1. IL-24: A novel gene therapy candidate for immune system upregulation in Hodgkin’s lymphoma
   Maryam Erfan Manesh et al, 2015, Journal of Medical Hypotheses and Ideas CrossRef
2. Mda-7/IL-24 enhances sensitivity of B cell lymphoma to chemotherapy drugs
   MING MA et al, 2016 CrossRef
3. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells
   Bing Han, 2015, WJG CrossRef
4. Mda-7/IL-24 induces the differentiation of B cell lymphoma via activation of the P38 mitogen activated protein kinase signaling pathway
   Ming Ma et al, 2017 CrossRef
5. Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients
   Ming Ma et al, 2018, Hematology CrossRef
6. Cancer terminator viruses (CTV ): A better solution for viral-based therapy of cancer
   Luni Emdad et al, 2018, J Cell Physiol CrossRef
7. null
   Mitchell E. Menezes et al, 2018 CrossRef
8. The Effect of RGD/NGR Peptide Modification of Melanoma Differentiation-Associated Gene-7/Interleukin-24 on Its Receptor Attachment, an In Silico Analysis
   Samaneh Bina et al, 2017, Cancer Biotherapy and Radiopharmaceuticals CrossRef
9. MDA-7/IL-24: multifunctional cancer killing cytokine.
   Mitchell E Menezes et al, 2014, Adv. Exp. Med. Biol. CrossRef
10. Twist in hepatocellular carcinoma: pathophysiology and therapeutics
    Hui Zou et al, 2015, Hepatol Int CrossRef
11. Macrophages promote the growth and invasion of endometrial stromal cells by downregulating IL-24 in endometriosis
    Jun Shao et al, 2016 CrossRef
12. Novel fusion protein NGR-sIL-24 for targetedly suppressing cancer cell growth via apoptosis
    Samira Valiyari et al, 2020, Cell Biol Toxicol CrossRef
13. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci
    Bo Liu et al, 2017, Oncotarget CrossRef
14. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
    Mitchell E Menezes et al, 2015, Oncotarget CrossRef
15. Lentivirus‑mediated MDA7/IL24 expression inhibits the proliferation of hepatocellular carcinoma cells
    Chao Ma et al, 2018, Mol Med Report CrossRef
16. The clinical significance of Mda‑7/IL‑24 and C‑myb expression in tumor tissues of patients with diffuse large B cell lymphoma
    Ming Ma et al, 2018, Exp Ther Med CrossRef
17. Therapeutic Approaches Targeting Molecular Signaling Pathways Common to Diabetes and Lung Diseases and Cancer
    Rajeswari Raguraman et al, 2021, Advanced Drug Delivery Reviews CrossRef
18. Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein
    Jinkal Modi et al, 2021, IJMS CrossRef
19. TCDD-induced IL-24 secretion in human chorionic stromal cells inhibits placental trophoblast cell migration and invasion
    Ge Liu et al, 2022, Reproductive Toxicology CrossRef
20. Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
    Minqi Zhang et al, 2022, Viral Immunology CrossRef
21. Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
    Lili Deng et al, 2022, Virol J CrossRef
22. WT1 Inhibits Human Renal Carcinoma Cell Proliferation and Induces G2/M Arrest by Upregulating IL-24 Expression
    Y. J. Jing et al, 2022, BioMed Research International CrossRef
23. Recent advances in oncolytic virus therapy for hepatocellular carcinoma
    Licheng Zhu et al, 2023, Front. Oncol. CrossRef